|
GNAQ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.114240E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.800200E-01 |
| Normal-vs-Stage2 |
5.332200E-01 |
| Normal-vs-Stage3 |
2.060100E-03 |
| Normal-vs-Stage4 |
3.030500E-04 |
| Stage1-vs-Stage2 |
5.660000E-01 |
| Stage1-vs-Stage3 |
2.638600E-04 |
| Stage1-vs-Stage4 |
5.54050000000084E-05 |
| Stage2-vs-Stage3 |
1.777190E-01 |
| Stage2-vs-Stage4 |
6.702400E-02 |
| Stage3-vs-Stage4 |
3.659000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.669970E-01 |
| Normal-vs-AfricanAmerican |
1.018150E-04 |
| Normal-vs-Asian |
9.194800E-01 |
| Caucasian-vs-AfricanAmerican |
3.986500E-04 |
| Caucasian-vs-Asian |
6.098400E-01 |
| AfricanAmerican-vs-Asian |
5.716400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.878400E-02 |
| Normal-vs-Female |
3.266200E-01 |
| Male-vs-Female |
2.271600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.713000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.215200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.543630E-02 |
| Normal-vs-Age(81-100Yrs) |
7.683400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.665800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.638000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.591970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.697800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.796100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.762430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.432160E-01 |
| Normal-vs-Grade 2 |
6.189200E-01 |
| Normal-vs-Grade 3 |
9.003100E-04 |
| Normal-vs-Grade 4 |
1.93471999999639E-05 |
| Grade 1-vs-Grade 2 |
3.141400E-01 |
| Grade 1-vs-Grade 3 |
1.218970E-03 |
| Grade 1-vs-Grade 4 |
1.576950E-04 |
| Grade 2-vs-Grade 3 |
1.47439999997889E-06 |
| Grade 2-vs-Grade 4 |
5.11619999699064E-08 |
| Grade 3-vs-Grade 4 |
3.930200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.068000E-01 |
| Normal-vs-ccB subtype |
4.844000E-02 |
| ccA subtype-vs-ccB subtype |
1.199790E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.715830E-01 |
| Normal-vs-N1 |
5.001600E-01 |
| N0-vs-N1 |
8.543600E-01 |
|
|
